Can Mohs surgery treat melanoma?

Patients often arrive at a skin cancer consult having read that Mohs surgery has the highest cure rate, then ask the natural follow-up: does that include melanoma? The honest answer is layered. Standard Mohs surgery, the same-day, margin-by-margin technique described in what is Mohs surgery, was developed for and is still used mostly on basal cell and squamous cell carcinomas. Melanoma is a different disease, and for years the two words in that sentence, melanoma and margins, did not fit neatly together. That is changing, and understanding how helps patients ask the right questions.

Why melanoma is treated differently. Melanoma arises from pigment-making cells and can spread to lymph nodes and beyond far more readily than the common skin cancers covered in basal cell vs. squamous cell carcinoma. Because of that, treatment is guided by tumor thickness and stage, not location alone, and the surgical margins are set by national guidelines rather than judged tumor by tumor on the day. A thin melanoma might call for a half-centimeter margin, a thicker one for two centimeters, numbers that come from decades of trials (National Cancer Institute). Most invasive melanoma is still treated with a planned wide local excision, sometimes paired with a sentinel lymph node biopsy to check whether cells have traveled.

Where Mohs enters the melanoma story. The frozen sections used in classic Mohs make melanoma cells hard to see clearly, which is why surgeons historically hesitated. Two adaptations solved much of that. The first is staged excision, sometimes called slow Mohs, in which the tissue is processed with permanent sections over a day or two rather than frozen on the spot, so the margin reading is more reliable. The second is the addition of immunostains, special stains that light up melanoma cells, allowing many centers to read melanoma margins accurately during a Mohs-style procedure. These techniques are used most for melanoma in situ (the earliest, non-invasive form) and for lentigo maligna, a slow melanoma on chronically sun-damaged skin of the face where sparing tissue matters enormously.

Why the face changes the calculation. On the cheek, nose, or ear, a two-centimeter margin can mean sacrificing tissue that is genuinely hard to replace, the same conservation logic that makes Mohs valuable for other cancers, explained in when Mohs is the right choice. For facial melanoma in situ, margin-controlled surgery with immunostains can clear the tumor while preserving more healthy skin than a standard wide excision drawn to a fixed measurement. Series from academic Mohs centers report high cure rates for these carefully selected cases (American College of Mohs Surgery).

What this means for a patient with a melanoma diagnosis. Read the pathology first: the words melanoma in situ, lentigo maligna, or a thickness in millimeters (the Breslow depth) change everything, which is why learning to read the report, as covered in what your skin biopsy report means, is worth the effort. Ask the surgeon three things: is this melanoma in situ or invasive, is margin-controlled or staged surgery an option for my case, and would a sentinel node biopsy be recommended. For invasive melanoma, expect a wide excision and a discussion of nodes rather than a same-day Mohs. For melanoma in situ on the face, ask specifically whether the practice uses immunostains, because that capability is what makes precise, tissue-sparing removal possible.

The takeaway. Mohs surgery, in its classic same-day form, is not the standard treatment for most melanoma, and anyone told they need melanoma surgery should understand that wide local excision remains the workhorse. But the technique's core idea, checking the actual margin instead of estimating it, has been adapted through staged excision and immunostaining to treat early and facial melanomas with excellent results and less lost tissue. If your diagnosis is melanoma in situ or lentigo maligna, especially on the face, it is entirely reasonable to seek a fellowship-trained Mohs surgeon who offers these methods and to ask how often they treat melanoma specifically. The American Academy of Dermatology maintains a plain-language overview of melanoma and its treatment options worth reading before the consult (American Academy of Dermatology).

Related reading: When Mohs is the right choice, and when it is not.